Aspirin (acetylsalicylic acid) is a non-steroidal anti-inflammatory drug (NSAID) and antiplatelet that is taken orally and commonly used for the treatment of pain. It is highly genericized and has been available in its present form since 1899, when it was first marketed by Bayer. Aspirin’s use as a possible ischemic stroke prevention medicine was first noted in the 1950s . For the treatment of ischemic stroke, antiplatelets are used to prevent thrombosis in atherosclerotic arteries to the brain.
LIST OF FIGURES
5 Figure 1: Datamonitor Healthcare’s drug assessment summary of Aspirin for ischemic stroke
6 Figure 2: Datamonitor Healthcare’s drug assessment summary of Aspirin for ischemic stroke
8 Figure 3: Aspirin sales for ischemic stroke across the US, Japan, and five major EU markets, by country, 2016–25
LIST OF TABLES
9 Table 1: Aspirin franchise sales for ischemic stroke across the US, Japan, and five major EU markets, by country ($m), 2016–25
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726